Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.

Boehm, Kevin Michael et al.·BMC bioinformatics·2019·
RPEP-040882019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.
Published In:
BMC bioinformatics, 20(1), 7 (2019)
Database ID:
RPEP-04088

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04088·https://rethinkpeptides.com/research/RPEP-04088

APA

Boehm, Kevin Michael; Bhinder, Bhavneet; Raja, Vijay Joseph; Dephoure, Noah; Elemento, Olivier. (2019). Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.. BMC bioinformatics, 20(1), 7. https://doi.org/10.1186/s12859-018-2561-z

MLA

Boehm, Kevin Michael, et al. "Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.." BMC bioinformatics, 2019. https://doi.org/10.1186/s12859-018-2561-z

RethinkPeptides

RethinkPeptides Research Database. "Predicting peptide presentation by major histocompatibility ..." RPEP-04088. Retrieved from https://rethinkpeptides.com/research/boehm-2019-predicting-peptide-presentation-by

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.